8-KEarnings & ResultsOther EventsExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Financial Results (Feb 2, 2023)

Filed February 2, 2023For Securities:DGX

Summary

Quest Diagnostics Inc. (DGX) filed an 8-K on February 2, 2023, detailing key financial and shareholder return actions. The company announced its financial results for the fourth quarter and full year ended December 31, 2022. While specific figures from the earnings release are not detailed in the 8-K itself, this filing serves as the official notification of their release, directing investors to Exhibit 99.1 for comprehensive performance data. Beyond earnings, the report highlights significant capital allocation decisions aimed at enhancing shareholder value. Quest Diagnostics' Board of Directors authorized an additional $1 billion for common stock repurchases, underscoring management's confidence in the company's stock and its commitment to returning capital to shareholders. Furthermore, the quarterly dividend was increased from $0.66 to $0.71 per share, marking the twelfth dividend increase since 2011, indicating a consistent track record of dividend growth.

Key Highlights

  • 1Quest Diagnostics announced its Q4 and full-year 2022 financial results via press release (Exhibit 99.1).
  • 2The company's Board of Directors authorized an additional $1 billion for common stock repurchases.
  • 3The quarterly dividend per share was increased by 7.6% from $0.66 to $0.71.
  • 4This marks the twelfth increase in Quest Diagnostics' quarterly dividend since 2011.
  • 5The increased dividend is effective for the payment on April 24, 2023, to shareholders of record on April 10, 2023.
  • 6The filing incorporates by reference two press releases detailing earnings and capital allocation actions.

Frequently Asked Questions

The specific financial results for the quarter and full year ended December 31, 2022, are detailed in the press release attached as Exhibit 99.1 to this 8-K filing. Investors should refer to that document for comprehensive financial performance data.

The Board of Directors authorized an *additional* $1 billion for common stock repurchases. This is an augmentation to the existing repurchase program, not necessarily the total authorized amount to date.

The increased quarterly dividend of $0.71 per share will be effective with the dividend payable on April 24, 2023. Shareholders of record as of April 10, 2023, will be entitled to receive this increased amount.

The increase in the quarterly dividend and the substantial authorization for share repurchases generally signal management's confidence in the company's financial stability, its ability to generate strong cash flows, and its commitment to returning value to shareholders. The consistent history of dividend increases further supports this positive outlook.